Plante Moran Financial Advisors, LLC Vertex Pharmaceuticals Inc Transaction History
Plante Moran Financial Advisors, LLC
- $1.2 Billion
- Q4 2024
A detailed history of Plante Moran Financial Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Plante Moran Financial Advisors, LLC holds 191 shares of VRTX stock, worth $93,292. This represents 0.01% of its overall portfolio holdings.
Number of Shares
191
Previous 192
0.52%
Holding current value
$93,292
Previous $89,000
14.61%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding VRTX
# of Institutions
1,712Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$13.1 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$11.3 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.4 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.77 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.4 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $125B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...